High Tide Inc. (2LYA.F)
EUR 2.85
(-2.9%)
EUR 2.85
(-2.9%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.53 CAD | 53.51% |
| 2022 | -1.14 CAD | -35.71% |
| 2021 | -0.84 CAD | -100.0% |
| 2020 | -0.42 CAD | 78.79% |
| 2019 | -1.98 CAD | -450.0% |
| 2018 | -0.36 CAD | -1692.92% |
| 2017 | 0.02 CAD | -99.16% |
| 2016 | 2.68 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.01 CAD | 3066.67% |
| 2024 Q2 | -0.00 CAD | 93.18% |
| 2024 Q1 | -0.00 CAD | 98.81% |
| 2023 Q3 | -0.05 CAD | -130.43% |
| 2023 Q2 | -0.02 CAD | 62.02% |
| 2023 Q1 | -0.05 CAD | 92.83% |
| 2023 FY | - CAD | 53.51% |
| 2023 Q4 | -0.37 CAD | -675.68% |
| 2022 Q3 | -0.04 CAD | 73.43% |
| 2022 Q1 | -0.14 CAD | -51.68% |
| 2022 Q4 | -0.76 CAD | -1943.01% |
| 2022 FY | - CAD | -35.71% |
| 2022 Q2 | -0.14 CAD | 0.0% |
| 2021 Q1 | -0.62 CAD | -463.64% |
| 2021 Q3 | -0.04 CAD | 87.47% |
| 2021 Q4 | -0.09 CAD | -145.48% |
| 2021 Q2 | -0.30 CAD | 51.61% |
| 2021 FY | - CAD | -100.0% |
| 2020 FY | - CAD | 78.79% |
| 2020 Q2 | -0.35 CAD | -12.9% |
| 2020 Q4 | -0.11 CAD | -140.74% |
| 2020 Q1 | -0.31 CAD | 71.3% |
| 2020 Q3 | 0.27 CAD | 177.14% |
| 2019 Q3 | -0.27 CAD | -8.0% |
| 2019 FY | - CAD | -450.0% |
| 2019 Q4 | -1.08 CAD | -300.0% |
| 2019 Q2 | -0.25 CAD | 19.35% |
| 2019 Q1 | -0.31 CAD | 11.43% |
| 2018 Q3 | -0.05 CAD | -52.65% |
| 2018 Q2 | -0.03 CAD | -221.77% |
| 2018 FY | - CAD | -1692.92% |
| 2018 Q4 | -0.35 CAD | -659.22% |
| 2018 Q1 | 0.02 CAD | 108.86% |
| 2017 Q3 | 0.68 CAD | 0.0% |
| 2017 Q4 | -0.28 CAD | -141.18% |
| 2017 FY | - CAD | -99.16% |
| 2016 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Newron Pharmaceuticals S.p.A. | -0.91 EUR | 41.758% |
| Redcare Pharmacy NV | -0.63 EUR | 15.873% |